Objective: To examine both the source of follistatin‐like protein 1 (FSTL‐1) and the factors that induce its expression in arthritis, and to determine whether juvenile rheumatoid arthritis (JRA) is characterized by overexpression of FSTL‐1.Methods: FSTL‐1 expression patterns were analyzed by immunohistochemical staining of joint tissue derived from mice with collagen‐induced arthritis. Induction of FSTL‐1 secretion was assessed in osteoblasts, adipocytes, and human fibroblast‐like synoviocytes in response to transforming growth factor β (TGFβ), interleukin‐1β (IL‐1β), tumor necrosis factor α (TNFα), and IL‐6. In addition, sera and synovial fluid from children with oligoarticular, polyarticular, or systemic‐onset JRA were assayed for FSTL‐1 using a custom enzyme‐linked immunosorbent assay. FSTL‐1 concentrations in these patients were assessed for correlations with the erythrocyte sedimentation rate (ESR) and platelet count.Results: Immunohistochemical staining of murine joint sections demonstrated expression of FSTL‐1 in all cell types of the mesenchymal lineage, including osteocytes, chondrocytes, adipocytes, and fibroblasts. FSTL‐1 could be induced in osteoblasts, adipocytes, and human fibroblast‐like synoviocytes by TGFβ, IL‐1β, TNFα, and IL‐6. The IL‐1β response was significantly greater than the TNFα response (P < 0.05). In human serum and synovial fluid, only those samples from children with the systemic‐onset JRA subtype had elevated concentrations of FSTL‐1. The synovial fluid concentrations of FSTL‐1 were 2–3‐fold higher than the serum concentrations. The elevation in serum FSTL‐1 concentrations seen in children with systemic‐onset JRA correlated closely with elevations in the ESR and platelet count.Conclusion: These findings demonstrate that the arthritic joint matrix is a major source of FSTL‐1 and that IL‐1β is a central mediator of FSTL‐1 secretion. Furthermore, FSTL‐1 may represent a useful biomarker of disease activity in systemic‐onset JRA.
Objective: FSTL1 is a secreted glycoprotein that exacerbates murine arthritis and is overexpressed in human arthritis. The aim of this study was to determine the mechanism by which FSTL1 promotes arthritis.Methods: Collagen‐induced arthritis was induced in mice hypomorphic for FSTL1, generated with a gene trap–targeted mutant embryonic stem cell line. Arthritis was assessed by measuring paw swelling and using a qualitative arthritis index. Bone marrow–derived mesenchymal stromal cells from hypomorphic mice, as well as mouse stromal ST2 cells transduced with short hairpin RNA to suppress FSTL1 expression, were stimulated with interleukin‐1β (IL‐1β), tumor necrosis factor α, and IL‐17. The monocyte cell line U937, which does not express FSTL1, was transfected with a plasmid encoding FSTL1 and stimulated with phorbol myristate acetate and lipopolysaccharide. Cell supernatants were assayed for IL‐6, IL‐8, monocyte chemotactic protein 1 (MCP‐1), and FSTL1 by enzyme‐linked immunosorbent assay.Results: FSTL1 hypomorphic mice had reduced levels of FSTL1 compared to littermate controls. Following induction of arthritis, a significant correlation was observed between serum FSTL1 levels and both paw swelling and the arthritis index. Similar correlations were observed between the amount of FSTL1 produced by mesenchymal stromal cells, stromal ST2 cells, and monocytes and the secretion of IL‐6, IL‐8, and MCP‐1.Conclusion: These findings demonstrate that FSTL1 up‐regulates proinflammatory mediators important in the pathology of arthritis, and that serum levels of FSTL1 correlate with severity of arthritis. The latter supports the possibility that FSTL1 might be a target for treatment of certain forms of arthritis.
Follistatin‐like protein 1 (FSTL‐1) is overexpressed in a number of inflammatory conditions characterized by elevated IL‐1β. Here, we found that FSTL‐1 serum concentration was increased threefold in patients with bacterial sepsis and fourfold following administration of LPS to mice. To test the contribution of FSTL‐1 to IL‐1β secretion, WT and FSTL‐1‐deficient mice were injected with LPS. While LPS induced IL‐1β in the sera of WT mice, it was low or undetectable in FSTL‐1‐deficient mice. Monocytes/macrophages, a key source of IL‐1β, do not normally express FSTL‐1. However, FSTL‐1 was found in tissue macrophages after injection of LPS into mouse footpads, demonstrating that macrophages are capable of taking up FSTL‐1 at sites of inflammation. In vitro, intracellular FSTL‐1 localized to the mitochondria. FSTL‐1 activated the mitochondrial electron transport chain, increased the production of ATP (a key activator of the nod‐like receptor family, pyrin domain containing 3 (NLRP3) inflammasome) and IL‐1β secretion. FSTL‐1 also enhanced transcription of the NLRP3 and procaspase 1 genes, two components of the NLRP3 inflammasome. Adenovirus‐mediated overexpression of FSTL‐1 in mouse paws led to activation of the inflammasome complex and local secretion of IL‐1β and IL‐1β‐related proinflammatory cytokines. These results suggest that FSTL‐1 may act on the NLRP3 inflammasome to promote IL‐1β secretion from monocytes/macrophages.
Objectives Chondrocytes, the only cells in the articular cartilage, play a pivotal role in osteoarthritis (OA) because they are responsible for maintenance of the extracellular matrix (ECM). Follistatin-like protein 1 (FSTL1) is a secreted protein found in mesenchymal stem cells (MSCs) and cartilage but whose function is unclear. FSTL1 has been shown to modify cell growth and survival. In this work, we sought to determine whether FSTL1 could regulate chondrogenesis and chondrogenic differentiation of MSCs. Methods To study the role of FSTL1 in chondrogenesis, we used FSTL1 knockout (KO) mice generated in our laboratory. Proliferative capacity of MSCs, obtained from skulls of E18.5 embryos, was analysed by flow cytometry. Chondrogenic differentiation of MSCs was carried out in a pellet culture system. Gene expression differences were assessed by microarray analysis and real-time PCR. Phosphorylation of Smad3, p38 MAPK and Akt was analysed by western blotting. Results The homozygous FSTL1 KO embryos showed extensive skeletal defects and decreased cellularity in the vertebral cartilage. Cell proliferation of FSTL1-deficient MSCs was reduced. Gene expression analysis in FSTL1 KO MSCs revealed dysregulation of multiple genes important for chondrogenesis. Production of ECM proteoglycans and collagen II expression were decreased in FSTL1-deficient MSCs differentiated into chondrocytes. Transforming growth factor β signalling in FSTL1 KO cells was significantly suppressed. Conclusions FSTL1 is a potent regulator of chondrocyte proliferation, differentiation and expression of ECM molecules. Our findings may lead to the development of novel strategies for cartilage repair and provide new disease-modifying treatments for OA.
CXC chemokines play a central role in regulation of neutrophil activation and chemotaxis. Because the chemotactic responses of neutrophils are impaired after phagocytosis, we explored the effect of phagocytic stimuli on the expression of interleukin-8 (IL-8) receptors, CXCR1 and CXCR2, in human neutrophils. After phagocytosis of opsonized yeast, the expression of CXCR1 and CXCR2 was substantially down-regulated and was accompanied by reduced Ca++responses to corresponding ligands, IL-8 and neutrophil-activating peptide–2 (NAP-2). The levels of CXCR1 and CXCR2 mRNA were constant during phagocytic stimulation of neutrophils. Confocal microscopy revealed that CXCR reduction was not via internalization. Metalloproteinase inhibitor, 1,10-phenantroline, prevented the reduction of CXCRs induced by phagocytosis, indicating that proteolytic degradation may be responsible for down-regulation. These observations suggest that down-regulation of CXCR expression may substantially reduce the responsiveness of phagocytosing neutrophils to CXC chemokines.